T1	Participants 439 524	Two hundred twenty-four patients with MBC and no prior therapy for metastatic disease
T2	Participants 1077 1085	Patients
T3	Participants 1330 1353	Median age was 54 years
T4	Participants 1603 1627	13% of TLC D-99 patients
T5	Participants 1667 1694	29% of doxorubicin patients
T6	Participants 1913 1941	26% in both treatment groups
